SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

INO RSS Feed
Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: Ubertino, TomP1
Search This Board: 
Last Post: 5/29/2017 10:33:46 AM - Followers: 412 - Board type: Free - Posts Today: 0

Logo: Inovio

www.inovio.com/

http://finance.yahoo.com/q/ks?s=INO

http://finance.aol.com/company/inovio-biomedical-corporation/ino/ase/institutional-ownership

F
ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE- http://www.youtube.com/watch?v=95yO6hFpbUM


Float: 97.65 M

Shares Outstanding: 127.26 M


Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
 
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis
http://finance.yahoo.com/news/inovio-pharmaceuticals-acquires-early-stage-080000624.html?.tsrc=applewf

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
http://finance.yahoo.com/news/inovio-pharmaceuticals-announces-1-4-080000629.html
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.


Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



 
 



 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
INO
Current Price
Volume:
Bid Ask Day's Range
PostSubject
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#13923   How can Kim make a million-and-a-half a year? redspinelpinktopaz 05/29/17 10:33:46 AM
#13922   FDA wants more shelf life data of the TomP1 05/27/17 04:42:58 PM
#13921   Silvr: why the clinical hold (Newby) and redspinelpinktopaz 05/27/17 10:16:23 AM
#13920   If it maintains at these current levels then Silvr Surfr 05/26/17 01:21:38 PM
#13919   Ought to have known this stock can't sustain radly 05/25/17 07:35:48 PM
#13918   * * $INO Video Chart 05-25-17 * * ClayTrader 05/25/17 04:15:36 PM
#13917   Hang on to those shares, don't let them Silvr Surfr 05/25/17 03:45:19 PM
#13916   added more but boxed a 35k short position harry crumb 05/25/17 11:53:42 AM
#13915   lol harry crumb 05/25/17 11:48:59 AM
#13914   I should have sold yesterday when up. kpisme 05/25/17 11:12:01 AM
#13913   Been holding for a long time. Still not ThatsThe1 05/24/17 07:02:26 PM
#13912   Been holding almost a year. Close to breakeven. radly 05/24/17 06:17:15 PM
#13911   * * $INO Video Chart 05-24-17 * * ClayTrader 05/24/17 04:57:49 PM
#13910   goo $ 6 beambe 05/24/17 03:57:55 PM
#13908   8.8 + 1.67 (23.42%) Ubertino 05/24/17 01:16:53 PM
#13907   I won't sell at $50. Ubertino 05/24/17 01:12:02 PM
#13906   $INO Daily and Weekly Chart http://stockchart $Pistol Pete$ 05/24/17 12:52:27 PM
#13905   Was not expecting this and nice b-day present fireopal 05/24/17 11:31:34 AM
#13904   form 4's tell the story! harry crumb 05/24/17 11:17:19 AM
#13903   ino will b bought out for 50+! harry crumb 05/24/17 11:16:11 AM
#13902   Somebody should tell that to MedImmune and Regeneron Tanis2476 05/24/17 11:01:16 AM
#13899   When will they treat HIV patients? Ubertino 05/24/17 10:23:45 AM
#13898   Effective in getting a immune response in healthy TomP1 05/24/17 10:20:01 AM
#13897   Why not! Ubertino 05/24/17 10:18:20 AM
#13896   A little premature to cal HIV dead, but TomP1 05/24/17 10:06:33 AM
#13895   Keep in mind this is a phase 1 TomP1 05/24/17 09:42:35 AM
#13892   HIV is dead; long live INO. Ubertino 05/24/17 09:31:36 AM
#13890   How about curing first? Prevention is the next level TomP1 05/24/17 09:20:50 AM
#13889   "Further studies will be needed to determine if davidsson10 05/24/17 09:19:08 AM
#13888   Great News for us longs!!! Silvr Surfr 05/24/17 09:14:20 AM
#13887   Inovio HIV Vaccine Elicits Nearly 100% Immune Response TomP1 05/24/17 09:13:48 AM
#13886   After over 3 years of disappointment, I finally treboriluap 05/24/17 09:07:59 AM
#13885   a day like this could be a good [SMART MONEY] 05/24/17 09:07:15 AM
#13884   It most certainly is! Tanis2476 05/15/17 10:40:05 AM
#13883   Welcome Back Miami Gent! Buy signal. Perkin78 05/15/17 09:00:34 AM
#13882   And Ebola! Ubertino 05/15/17 08:57:24 AM
#13881   Zika Season ! biotechnician 05/15/17 08:39:21 AM
#13880   INO Little doubt it was a stock grant MiamiGent 05/13/17 06:27:40 PM
#13879   Advisory : INO is a scam stock run in MiamiGent 05/13/17 04:29:56 PM
#13878   INO is a gem worth at least $10,000/s. Ubertino 05/13/17 01:29:03 PM
#13876   Ebola is out again in Congo, 3 people Kahoona1962 05/12/17 12:44:27 PM
#13875   I'm smelling $100....soon. Ubertino 05/12/17 12:07:59 PM
#13874   I'm smelling FDA release of clinical hold maybe?! Silvr Surfr 05/12/17 10:25:51 AM
#13873   Hang on for the ride folks this stock Silvr Surfr 05/12/17 10:17:30 AM
#13872   https://www.americanbankingnews.com/2017/04/27/positive-news-coverage-likely-to- radly 04/28/17 10:10:16 PM
#13871   So much for that bump! radly 04/28/17 06:53:38 PM
#13870   http://www.capitalcube.com/blog/index.php/inovio-pharmaceuticals-inc-value-analy radly 04/27/17 08:53:23 PM
#13869   Nice little bump the last few days. Come radly 04/25/17 04:51:58 PM
#13868   I hope everyone got on board when I Silvr Surfr 04/25/17 09:38:25 AM
#13867   The share price lags and soars based on conceptions. Ubertino 04/25/17 09:19:18 AM
PostSubject